The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|3|328-334

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.3, 2015-03, pp. : 328-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adefovir Dipivoxil for Treatment of Breakthrough Hepatitis Caused by Lamivudine-Resistant Mutants of Hepatitis B Virus

By  

Intervirology, Vol. 47, Iss. 6, 2004-11 ,pp. : 362-369

Karger

Access to resources Recommend Favorite

Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil

By  

Intervirology, Vol. 51, Iss. 6, 2009-02 ,pp. : 385-393

Karger

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 85-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Up-regulation of Foxo4 mediated by hepatitis B virus X protein confers resistance to oxidative stress-induced cell death

By                          

International Journal of Molecular Medicine, Vol. 28, Iss. 2, 2011-01 ,pp. : 255-260

Spandidos Publications

Access to resources Recommend Favorite

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

By  

Intervirology, Vol. 57, Iss. 1, 2013-08 ,pp. : 8-16

Karger

Access to resources Recommend Favorite